  Succinylcholine (Anectine, Quelicin) section { margin-bottom: 20px; } table { border-collapse: collapse; } table, tr, th, td { border: 1px solid black; } th, td { padding: 0px 8px 0px 8px; text-align: left; vertical-align: top; } h3, p, ol.custom-counter, li { margin: 0px; padding: 0px; } .text-red { color: red; } .text-black { color: black; } ul.custom-dash { list-style: none; padding-left: 0; margin: 0; } ul.custom-dash > li { display: flex; align-items: flex-start; } ul.custom-dash > li::before { content: "–"; margin-right: 0.5em; flex-shrink: 0; line-height: 1; } ul.custom-dash > li > \*:not(::before) { flex: 1; } ul.custom-dash > li.no-dash::before { content: ""; width: 1em; margin-right: 0.5em; flex-shrink: 0; } /\* Change the ol style \*/ ol.custom-counter { list-style: none; padding-left: 0; counter-reset: custom calc(var(--start, 1) - 1); } ol.custom-counter li { counter-increment: custom; margin-bottom: 5px; } ol.custom-counter li::before { content: counter(custom) ") "; } /\* This is just for this file \*/ ul.custom-bullet-arrow { list-style: none; padding-left: 0; margin: 0; } ul.custom-bullet-arrow > li { display: flex; align-items: flex-start; } ul.custom-bullet-arrow > li::before { content: "↑"; margin-right: 0.5em; flex-shrink: 0; } ul.custom-bullet-arrow > li.no-arrow::before { content: ""; width: 0.5em; margin-right: 0.5em; flex-shrink: 0; } ul.custom-bullet\_arrow ul { list-style-type: disc; padding-left: 1.5em; margin-top: 0.5em; } img.resized-200 { width: 200px; height: auto; } img.resized-400 { width: 400px; height: auto; } img.resized-600 { width: 600px; height: auto; } .mb-10px { margin-bottom: 10px; } .mb-20px { margin-bottom: 20px; } .mt-10px { margin-top: 10px; } .mt-20px { margin-top: 20px; } .reference-notes { font-size: 11px; } .text-indent-45px { text-indent: 45px; } .text-bold { font-weight: bold; }

### Atracurium (Atracurium besylate)

<table><tbody><tr><th style="width: 140px;">Class</th><td><p>Nondepolarizing Muscle Blocker (NDMB)</p><p>Intermediate acting</p></td></tr><tr><th>Subclass</th><td><p>Benzylisoquinoline</p></td></tr><tr><th>Structure</th><td><p>A quaternary ammonium compound</p></td></tr><tr><th>Quick notes</th><td><p>A mixture of the 10 stereoisomers</p><p>Cisatracuronium is now the preffered Benzylisoquinoline of choice for liver and renal failure.</p><p>Most hospital pharmacies no longer stock Atracuronium.</p></td></tr><tr><th>Indications</th><td><p>Aid in intubation and relaxation of skeletal muscle during surgery</p></td></tr><tr><th>Action</th><td><p>Binds competitively to cholinergic receptors in motor end-plate neurons,</p><p>blocking acetylcholine from accessing the receptors.</p></td></tr><tr><th>Onset</th><td><p>3-5 minutes</p></td></tr><tr><th>Duration</th><td><p>20-35 minutes</p></td></tr><tr><th>Elimination<br>Half-life</th><td><p>20 minutes</p></td></tr><tr><th>Induction Dose</th><td><p>0.5 mg/kg IV</p></td></tr><tr><th>Maintenance</th><td><p>0.08 to 0.10 mg/kg</p></td></tr><tr><th>Infusion dose</th><td><p>Literature varies and ranges anywhere from 3-29.5 mcg/kg/min</p><p>Titrate to 1-2 twitches TOF</p></td></tr><tr><th>Histamine release</th><td><p>Yes, less favorable hemodynamic profile than Cisatracuronium</p><p>However, histamine release is rarely seen with &lt; 2 x ED95</p></td></tr><tr><th>Metabolism</th><td><p><b>Hofmann Elimination:</b> pH and temperature-dependent</p></td></tr><tr><th>Metabolites</th><td><p>Produces more laudanosine than Cisatracuronium.</p><p>Laudanosine may accumulate with prolonged continuous infusions in patients with renal impairment.</p><p>It may cross the blood-brain barrier, potentially leading to excitatory effects and seizure activity.</p></td></tr><tr><th>Pregnancy Classification</th><td><p><b>Class C.</b> Studies showed some risk, but there were no adequate studies in pregnant women.</p><p>Only a minimal amount of atracurium crosses the placenta.</p></td></tr><tr><th>Breast feed</th><td><p>Unlikely to reach the infant's bloodstream due to its high polarity and poor oral absorption.</p><p>Breastfeeding can likely resume once the medication's effects have worn off.</p></td></tr><tr><th>pH</th><td><p>3.00 to 3.65</p></td></tr><tr><th>Incompatible with</th><td><p>Alkaline solutions such as sodium bicarbonate and thiopental</p><p>ketorolac or propofol for Y-site continuous infusion</p><p>It may precipitate in a line containing an alkaline solution</p></td></tr><tr><th>Diluent for infusion</th><td><p>Avoid LR and use NSS</p><p>Atracurium degrades more rapidly in LR</p></td></tr><tr><th>Contraindications</th><td><p>Hypersensitivity to Atracurium or benzyl alcohol</p><p>CV patients who can't tolerate histamine release</p></td></tr><tr><th>Reversal agent</th><td><p>Neostigmine, edrophonium, or pyridostigmine with an anticholinergic agent.</p><p>Sugammadex <span class="text-red">WILL NOT</span> reverse Benzylisoquinoline NMBDs.</p></td></tr><tr><th>Elimination</th><td><p>&lt; 5% is excreted in the urine</p><p>Laudanosine is hepatically and renally eliminated and has a significantly longer elimination half-life than atracurium (197 minutes).</p></td></tr><tr><th>Adverse reactions</th><td><p>hypotension, tachycardia, bronchospasm,</p><p>laudanosine toxicity, allergic reactions</p></td></tr><tr><th>Vol of distribution</th><td><p>160 mL/kg</p></td></tr><tr><th>Plasma protein binding</th><td><p>82%</p></td></tr><tr><th>Drugs that enhance</th><td><p>Inhalation agents, local anesthetics….</p><p>See the list at the bottom of this page.</p></td></tr><tr><th>Drugs that decrease the duration</th><td><p>phenytoin or carbamazepine (anticonvulsants)</p></td></tr><tr><th>Vial strength:</th><td><p>10 mg/mL</p></td></tr><tr><th>Kept refrigerated</th><td><p>Yes, at 2 to 8 °C</p><p>Do not freeze.</p><p>Protected from light to preserve potency.</p><p>The potency loss rate is as high as 5-10% monthly at room temperature.</p><p>Once removed from refrigeration to room temperature storage,</p><p>it should be used within 14 days.</p></td></tr></tbody></table>

Drugs that enhance atracurium:

Magnesium salts

Bacitracin

Polymixin b

Calcium channel blockers

Procainamide

Clindamycin

Quinidine

Colistin quinine

Ketorolac

Sodium Colistiemethate

Lincomycin

Spironolactone

Lithium

Tetracyclines

Vancomycin

Loop diuretics

Aminoglycosides (include gentamicin, tobramycin, amikacin, neomycin, and streptomycin)

Drugs that contain ammonium compounds may trigger an allergic reaction with hairdressers.

-   A study suggests that repetitive exposure to quaternary ammonium compounds used in hairdressing is a risk factor for sensitization to certain muscle relaxants.
-   Hairdressers are routinely exposed to a wide range of hair products containing the quaternary ammonium compound.
-   This repeated exposure to quaternary ammonium compounds can lead to the development of IgE antibodies specific.
-   Atracurium contains a quaternary ammonium.
-   After the administration of atracurium, the quaternary ammonium can act as an antigenic epitope, triggering an immune response in sensitized individuals and possibly an anaphylactic reaction.
-   One study showed that 7.4% of hairdressers had IgE antibodies to quaternary ammonium, compared to only 1.6% of non-hairdressing apprentices.
-   However, this was only a study and lacks the data of hairdressers having allergic reactions from drugs that contain a quaternary ammonium.

Atracurium

ATRACURIUM BESYLATE- atracurium besylate injection, solution

Hospira, Inc.

Pfizer.com (accessed 09/2025)

https://labeling.pfizer.com/ShowLabeling.aspx?id=4665

Atracuronium

Morgan & Mikhail’s Clinical Anesthesiology 7th Ed., 2022

CH.11, Neuromuscular Blocking Agents, p. 206, 210

Atracurium

StatPearls (accessed 09/2024)

Matthew L. Ritz; Armen Derian.

https://www.ncbi.nlm.nih.gov/books/NBK499995/

Atracurium FDA

Access.gov (accessed 09/2025)

https://www.accessdata.fda.gov/drugsatfda\_docs/anda/98/74944\_Atracurium%20Besylate\_Prntlbl.pdf

Prevalence of IgE against neuromuscular blocking agents in hairdressers and bakers

Clinical & Experimental Allergy, 2013;43:1256-1262

Dong S, Acouetey DS, Guéant-Rodriguez R-M, Zmirou-Navier D, Rémen T, Blanca M, Mertes PM, Guéant J-L